Christopher Wild

1.6k total citations
32 papers, 1.2k citations indexed

About

Christopher Wild is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Christopher Wild has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Christopher Wild's work include Receptor Mechanisms and Signaling (8 papers), Bioactive Natural Diterpenoids Research (5 papers) and Chemical Synthesis and Analysis (3 papers). Christopher Wild is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Bioactive Natural Diterpenoids Research (5 papers) and Chemical Synthesis and Analysis (3 papers). Christopher Wild collaborates with scholars based in United States, China and Germany. Christopher Wild's co-authors include Na Ye, Jia Zhou, Ye Ding, Qiang Shen, Haiying Chen, Zhiqing Liu, Chunyong Ding, Haijun Chen, Eric A. Wold and Mark A. White and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Christopher Wild

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Wild United States 17 804 204 161 132 125 32 1.2k
Sonia Lobo Planey United States 15 807 1.0× 297 1.5× 91 0.6× 255 1.9× 103 0.8× 26 1.7k
Yuanjun He United States 18 1.2k 1.5× 269 1.3× 73 0.5× 203 1.5× 126 1.0× 34 1.8k
Daniel S. Sem United States 24 1.1k 1.3× 170 0.8× 186 1.2× 184 1.4× 119 1.0× 86 1.8k
Nam Sook Kang South Korea 20 526 0.7× 232 1.1× 70 0.4× 185 1.4× 126 1.0× 97 1.2k
Ted W. Johnson United States 18 790 1.0× 395 1.9× 82 0.5× 156 1.2× 93 0.7× 28 1.6k
Navnath S. Gavande United States 20 791 1.0× 215 1.1× 61 0.4× 242 1.8× 84 0.7× 52 1.2k
Qiancheng Shen China 22 1.1k 1.4× 200 1.0× 95 0.6× 116 0.9× 58 0.5× 33 1.5k
Ke‐He Ruan United States 23 733 0.9× 100 0.5× 123 0.8× 110 0.8× 377 3.0× 79 1.4k
Kevin P. Madauss United States 19 783 1.0× 162 0.8× 90 0.6× 454 3.4× 98 0.8× 28 1.6k
Jeffrey S. Wiseman United States 22 663 0.8× 243 1.2× 62 0.4× 169 1.3× 117 0.9× 52 1.6k

Countries citing papers authored by Christopher Wild

Since Specialization
Citations

This map shows the geographic impact of Christopher Wild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Wild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Wild more than expected).

Fields of papers citing papers by Christopher Wild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Wild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Wild. The network helps show where Christopher Wild may publish in the future.

Co-authorship network of co-authors of Christopher Wild

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Wild. A scholar is included among the top collaborators of Christopher Wild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Wild. Christopher Wild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fox, Robert G., Christopher Wild, Eric A. Wold, et al.. (2024). Serendipitous Discovery of Novel 5-HT2AR Positive Allosteric Modulators (PAMs) Derived From 5-HT2CR PAM Scaffolds. Journal of Pharmacology and Experimental Therapeutics. 389. 87–87.
2.
Chen, Jianping, Konrad Pazdrak, Susan Stafford, et al.. (2023). Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators. Journal of Medicinal Chemistry. 66(14). 9992–10009. 7 indexed citations
3.
Kuang, Yuting, Na Ye, Mats Ljungman, et al.. (2022). Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer. Journal of Medicinal Chemistry. 65(8). 6133–6156. 5 indexed citations
4.
Wold, Eric A., Christopher Wild, Joanna Miszkiel, et al.. (2020). Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties. Journal of Medicinal Chemistry. 63(14). 7529–7544. 15 indexed citations
5.
Wold, Eric A., Christopher Wild, Kathryn A. Cunningham, & Jia Zhou. (2019). Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. Current Topics in Medicinal Chemistry. 19(16). 1381–1398. 41 indexed citations
6.
Ding, Ye, Chunyong Ding, Na Ye, et al.. (2016). Discovery and development of natural product oridonin-inspired anticancer agents. European Journal of Medicinal Chemistry. 122. 102–117. 148 indexed citations
7.
Wild, Christopher, Yingmin Zhu, Fang Mei, et al.. (2016). Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors. ACS Medicinal Chemistry Letters. 7(5). 460–464. 17 indexed citations
8.
Liu, Zhiqing, Christopher Wild, Ye Ding, et al.. (2015). BH4 domain of Bcl-2 as a novel target for cancer therapy. Drug Discovery Today. 21(6). 989–996. 43 indexed citations
9.
10.
Liu, Zhiqing, Ye Ding, Na Ye, et al.. (2015). Direct Activation of Bax Protein for Cancer Therapy. Medicinal Research Reviews. 36(2). 313–341. 195 indexed citations
11.
Wang, Lili, Zhengduo Yang, Qing Xia, et al.. (2015). Abstract P6-12-04: Targeting STAT3 with novel small molecule inhibitors to sensitize breast cancer cells to radiation therapy. Cancer Research. 75(9_Supplement). P6–12. 1 indexed citations
12.
Chen, Haijun, Zhengduo Yang, Chunyong Ding, et al.. (2014). Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3). European Journal of Medicinal Chemistry. 82. 195–203. 48 indexed citations
13.
Chen, Haijun, Chunyong Ding, Christopher Wild, et al.. (2013). Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist. Tetrahedron Letters. 54(12). 1546–1549. 31 indexed citations
14.
Ding, Chunyong, Yusong Zhang, Haijun Chen, et al.. (2013). Oridonin Ring A-Based Diverse Constructions of Enone Functionality: Identification of Novel Dienone Analogues Effective for Highly Aggressive Breast Cancer by Inducing Apoptosis. Journal of Medicinal Chemistry. 56(21). 8814–8825. 72 indexed citations
15.
16.
Chen, Haijun, Christopher Wild, Xiaobin Zhou, et al.. (2013). Recent Advances in the Discovery of Small Molecules Targeting Exchange Proteins Directly Activated by cAMP (EPAC). Journal of Medicinal Chemistry. 57(9). 3651–3665. 33 indexed citations
17.
Chen, Haijun, Cheng Z. Wang, Chunyong Ding, et al.. (2012). A Combined Bioinformatics and Chemoinformatics Approach for Developing Asymmetric Bivalent AMPA Receptor Positive Allosteric Modulators as Neuroprotective Agents. ChemMedChem. 8(2). 226–230. 20 indexed citations
18.
Joppi, Roberta & Christopher Wild. (2012). Vemurafenib for patients with BRAF V600E mutation positive advanced/metastatic melanoma. 1 indexed citations
19.
Wild, Christopher, et al.. (2007). Funktionelle Ergebnisse nach Laservaporisation der Prostata mit dem KTP-Laser. Der Urologe. 46(5). 521–527. 2 indexed citations
20.
Wild, Christopher. (2004). Intraoperative radiotherapy in early stage breast cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Lobo Planey Breakdown of academic impact, for papers by Yuanjun He Breakdown of academic impact, for papers by Daniel S. Sem Breakdown of academic impact, for papers by Nam Sook Kang Breakdown of academic impact, for papers by Ted W. Johnson Breakdown of academic impact, for papers by Navnath S. Gavande Breakdown of academic impact, for papers by Qiancheng Shen Breakdown of academic impact, for papers by Ke‐He Ruan Breakdown of academic impact, for papers by Kevin P. Madauss Breakdown of academic impact, for papers by Jeffrey S. Wiseman
Rankless by CCL
2026